Solar Foods starts Factory01
Finnish Solar Foods Oy has started microbial production of its protein powder Solein in Factory 01, Solar Foods’ first commercial-scale production facility in Vantaa, Finland.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1344 entries already.
Entries by Thomas Gabrielczyk
Shock: Adrenomed AG gets FDA fast track designation
/in News/by Thomas GabrielczykGerman AdrenoMed AG has got FDA Fast Track designation for its targeted septic shock medicine enibarcimab that restores endothel integrity. <br /><br /><br /><br />
Lonza AG enters R&D collaboration with NeuroSense Therapeutics Ltd
/in News/by Thomas GabrielczykALS specialist NeuroSense Therapeutics Ltd announces it will be collaborating with Swiss Lonza AG to identify exosome-based biomarkers to advance theranostics in neurodegeneration.
Essential Pharma acquires Renaissance Pharma Ltd
/in News/by Thomas GabrielczykEssential Pharma has acquired Renaissance Pharma Ltd to commercialise the company’s Phase II program Hu14.18K322A in pedriatric high-risk neuroblastoma.<br /><br />
Unitaid awards Medincell US$6m to fight malaria
/in News/by Thomas GabrielczykGlobal health agency Unitaid has awarded French Medincell Corp (Jacou) an extension grant of up to US$ 6 million over three years to fund thesatety testing of its malaria vaccine […]
Genmab broadens ADC pipeline with $1.8bn acquisition of ProfoundBio
/in News/by Thomas GabrielczykGenmab announced today that it will acquire privately held biotech company ProfoundBio for $1.8bn in cash. The deal is designed to help the Danish pharmaceutical company deepen its cancer pipeline […]
TME Pharma gets FDA Fast Track for Glioblastoma
/in News/by Thomas GabrielczykTME Pharma (France/Germany) announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for NOX-A12 (olaptesed pegol), TME Pharma's CXCL12 inhibitor, in combination with radiotherapy and bevacizumab […]
Forbion participates in US financing rounds
/in News/by Thomas GabrielczykForbion, the European life sciences venture capital firm from The Netherlands, announced its participation in oversubscribed Series B financing in Capstan Therapeutics Inc. and Engrail Therapeutics. Both companies are located […]
New law to speed up clinical trials
/in News/by Thomas GabrielczykWith a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again.
Gut bacteria seed autoimmunity-inducers
/in News/by Thomas GabrielczykA bacterium of the gut microbiome seems to spark an autoimmune disease in the kidneys by leaking antigens that trigger the immune system.